SR&ED Just Changed in Canada — Here’s What I Think Actually Matters for Founders

On this page

Last week, Canada passed the most significant updates to the SR&ED program in over a decade. After years of advocacy from many groups and Canadian leaders, major reforms to Canada’s Scientific Research and Experimental Development (SR&ED) program take effect today.

You’ve likely already seen the headlines and all the "hot takes" but the real question is what these changes mean for how you build your company.

For years, SR&ED hasn’t kept pace with how modern companies operate. Limits didn’t move with inflation, capital-heavy innovation was at a disadvantage, and many companies outgrew the program earlier than they should have. What we’re seeing now is less about generosity and more about the government catching up.

Arguably the most active group in pushing for these updates is the Canadian Council of Innovators and as members of CCI, we’ve had a front-row seat to many of the conversations shaping these changes.

The direction is clear: this is about making SR&ED more relevant to how companies actually build today.

The Updates

On paper, the changes are straightforward:

  • capital expenditures are eligible again,
  • expenditure limits for CCPCs have doubled from $3M to $6M,
  • taxable capital thresholds have expanded,
  • and certain public companies can now access refundable credits (Canadian-listed firms, that are Canadian-controlled and their Canadian-based subsidiaries)

Individually, these look like incremental improvements. Taken together, they materially increase the amount of non-dilutive capital available to innovative companies.

For some businesses, refundable SR&ED can now reach over $2M annually. That’s no longer a marginal benefit, it’s meaningful runway.This shift also changes who benefits most. Bringing capital expenditures back into the program is particularly significant for companies investing heavily in infrastructure, equipment, or technical systems. Hardware, manufacturing, and deep tech businesses, historically disadvantaged under SR&ED, are now much better positioned to benefit. At the same time, higher limits and expanded eligibility mean the program extends further into the growth stage, and the belief that this is just for "early stage" companies can be rebutted.

I think these changes should change behaviour in material way.

The Mindset Shift

Historically, SR&ED has been treated by most companies as a retrospective exercise. You build, you document, and you file. You optimize around the edges.

We tell our customers (and have been for some time!) that this is an outdated and ineffective approach.  And now, when the program becomes this material, and when capital and scale are more meaningfully included, it starts to influence decisions upstream. Hiring plans, technical direction, capital allocation, and the timing of investment all become part of the equation. SR&ED moves from something you deal with after the fact to something you can design around and plan for in a strategic way.

New: The Pre Claim Approval Process

One area where we see a lot of optimism, and where we take a more cautious view, is in the new Pre-Claim Approval process (PCA). In theory, this offers certainty before work begins, along with faster processing and reduced audit risk. On the surface, that’s appealing. But innovation rarely follows a fixed path.

Projects evolve, scope shifts, and technical challenges change direction. Locking in assumptions early may limit flexibility later, whether that means under-claiming or constraining how work develops. Certainty has value, but in this context, it might come at a cost. For many companies, especially those iterating quickly, flexibility could bemore important.That doesn’t mean pre-claim approvals won’t have a place. It does mean they should be approached thoughtfully, not automatically and we will continue to watch this space.

Final Thoughts

Overall, the risk is that companies interpret these changes too narrowly. It’s easy to see this as simply “more funding” or a larger claim opportunity. In reality, the bigger shift is strategic.

SR&ED is no longer just about maximizing what you did, it’s increasingly about shaping what you choose to do.The companies that benefit most won’t be the ones that file the "best" claims. They’ll be the ones that plan more deliberately, align their technical and financial decisions earlier, and treat SR&ED as part of how they build, not just how they report.

I think we can all agree that the Canadian government has made it easier to fund innovation with these updates. This is a meaningful step forward but it doesn’t change the fundamentals. Building a great company still comes down to execution, judgment, and timing. These program improvements have been a long time coming and as CCI noted, "now the focus is on making sure it works in practice and continues to improve."

SR&ED is a more powerful tool than it was before. What matters is how you choose to use it.

Related posts

Your next funding opportunity is closing soon

Let’s connect before it's too late.